Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10967677 | Vaccine | 2013 | 8 Pages |
Abstract
Although immune response after full series of combined HAV and HBV vaccine in both groups was excellent and comparable to healthy children, a substantial proportion of both groups was not protected for HAV after first dose of vaccine. This protection gap is especially important for HAV in travel health and postexposure prophylactic treatment: both groups of children should be serologically tested for anti-HAV prior to travel to ensure protection if there is no time to await second dose of vaccine.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sanne-Meike Belderok, Gerard J.B. Sonder, Marion van Rossum, Annette van Dijk-Hummelman, Nico Hartwig, Henriette Scherpbier, Sibyl Geelen, Arjen G.C.L. Speksnijder, Gijs Baaten, Anneke van den Hoek,